CDK9 and cardiac hypertrophy: Previous work has demonstrated that a dominant-negative CDK9 construct blocks ET-1-induced hypertrophy in cultured mouse cardiomyocytes (Sano et al., 2002), confirming a key role for the protein in cardiac hypertrophy.